Multi-Omics Identifies Circulating miRNA and Protein Biomarkers for Facioscapulohumeral Dystrophy

The development of therapeutics for muscle diseases such as facioscapulohumeral dystrophy (FSHD) is impeded by a lack of objective, minimally invasive biomarkers. Here we identify circulating miRNAs and proteins that are dysregulated in early-onset FSHD patients to develop blood-based molecular biom...

Descripción completa

Detalles Bibliográficos
Autores principales: Heier, Christopher R., Zhang, Aiping, Nguyen, Nhu Y, Tully, Christopher B., Panigrahi, Aswini, Gordish-Dressman, Heather, Pandey, Sachchida Nand, Guglieri, Michela, Ryan, Monique M., Clemens, Paula R., Thangarajh, Mathula, Webster, Richard, Smith, Edward C., Connolly, Anne M., McDonald, Craig M., Karachunski, Peter, Tulinius, Mar, Harper, Amy, Mah, Jean K., Fiorillo, Alyson A., Chen, Yi-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711540/
https://www.ncbi.nlm.nih.gov/pubmed/33228131
http://dx.doi.org/10.3390/jpm10040236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711540/
https://www.ncbi.nlm.nih.gov/pubmed/33228131
http://dx.doi.org/10.3390/jpm10040236

Ejemplares similares